Review of drug subsidy scheme delayed as test case looms.
作者信息
Burton Bob
出版信息
BMJ. 2006 Dec 16;333(7581):1239. doi: 10.1136/bmj.39062.420995.DB.
Abstract
摘要
相似文献
1
Review of drug subsidy scheme delayed as test case looms.由于测试案例即将出现，药品补贴计划的审查被推迟。
BMJ. 2006 Dec 16;333(7581):1239. doi: 10.1136/bmj.39062.420995.DB.
2
Costing drug development.药物研发成本核算
Nat Rev Drug Discov. 2003 Apr;2(4):247. doi: 10.1038/nrd1070.
3
Medicine and the pharmaceutical industry.医学与制药行业。
Dev Med Child Neurol. 2006 Aug;48(8):627. doi: 10.1017/S0012162206001320.
4
US policy keeps drugs out of reach in clinical trials abroad.美国政策使国外临床试验中的药物难以获取。
Nat Med. 2005 May;11(5):460. doi: 10.1038/nm0505-460a.
5
[The world population does not have the drugs it needs. WHO report recommends more stringent control of the drug industry].
Lakartidningen. 2005;102(7):450-1.
6
Pharmaceutical advertising versus research spending: are profits more important than patients?药品广告与研究支出：利润比患者更重要吗？
Am Heart J. 2003 Oct;146(4):563-4. doi: 10.1016/S0002-8703(03)00399-5.
7
Drug price deal spells windfall for researchers.药品价格协议为研究人员带来意外之财。
Nature. 2001 Nov 8;414(6860):138. doi: 10.1038/35102709.
8
Technology development from the perspective of industry.
J Invasive Cardiol. 1993 Mar;5(2):65-8.
9
NIH urged to cap profits made on publicly funded research.美国国立卫生研究院被敦促限制利用公共资金资助的研究获取的利润。
Nature. 2000 Jul 6;406(6791):5. doi: 10.1038/35017714.
10
Costs of research and patent considerations.研究成本与专利考量
J Androl. 1987 Jan-Feb;8(1):S27-32.
Zotero 插件